Posted by Michael Wonder on 24 Feb 2020
ICER to assess evidence on supervised injection facilities and digital apps for opioid use disorder
21 February 2020 - ICER expands its reviews in area of ongoing public health crisis related to opioid addiction.
The Institute for Clinical and Economic Review (ICER) today announced plans to assess the comparative clinical effectiveness and economic value of two non-drug topics: supervised injection facilities (SIFs) and digital apps for opioid use disorder.
Along with past ICER assessments of related topics such as abuse-deterrent opioid formulations, medication-assisted treatment for opioid use disorder, and non-drug interventions for lower back pain, today’s announcement reinforces ICER’s commitment to provide policymakers with an independent evaluation of the evidence around interventions to address the public health crises stemming from the opioid epidemic in the United States.
